September 2018 Briefing – Infectious Disease
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for September 2018. This roundup includes the...
Risk of Venous Thromboembolism Recurrence High
At 6 months, rates for provoked, unprovoked, cancer-related VTE are 6.8, 6.92, 9.06 per 100 person-years
More Non-Elderly Americans Uninsured in 2017 Versus 2016
More than 700,000 Americans uninsured in 2017 versus 2016, despite broad economic improvement
Hospital Privacy Curtains Become Increasingly Contaminated
Ten to 14 days after being hung, curtains show increased MRSA positivity
First Human Case of Rat Strain of Hepatitis E Seen in Hong Kong
Infection identified in 56-year-old man who had received a liver transplant in May 2017
WHO: ‘Very High Risk’ That Ebola Will Spread From Congo
Agency says two cases of the deadly virus were confirmed near the border with Uganda
FDA Approves New Drug for Antibiotic-Resistant Lung Disease
Arikayce approved to treat lung disease caused by Mycobacterium avium complex bacteria
No Benefit to Negative Pressure Wound Therapy After C-Section
Compared with standard dressings, no reduction in superficial surgical site infections in obese women
CDC: Congenital Syphilis More Than Doubled Since 2013
Congenital syphilis up from 362 cases in 2013 to 918 in 2017, with 46.17 percent increase since 2016
Pharmaceutical Executive Defends 400 Percent Price Hike
Price for nitrofurantoin increased from $474.75 to $2,392 in August; exec cites 'moral imperative'
